Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1500011	奥法妥木单抗注射液	ofatumumab	Injection	Biological Products	Import Drug Application	2015-04-30	Glaxo Group Limited	Glaxo Group Ltd	Certificate Issued	2016-05-16	view
JXHL1400039	糠酸氟替卡松维兰特罗粉雾剂(Ⅱ)	fluticasone furoate;vilanterol	Powder for inhalation	Chemical Drugs	Import Drug Application	2014-02-13	Glaxo Group Limited	Glaxo Group Ltd	Certificate Issued	2016-09-26	view
JXHS1500046	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Import Drug Application	2015-05-08	Glaxo Group Limited	Glaxo Group Ltd	Certificate Issued	2017-02-28	view
JXHS1500047	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Import Drug Application	2015-05-08	Glaxo Group Limited	Glaxo Group Ltd	Certificate Issued	2017-02-28	view
JXHL1400038	糠酸氟替卡松维兰特罗粉雾剂(Ⅲ)	fluticasone furoate;vilanterol	Powder for inhalation	Chemical Drugs	Import Drug Application	2014-02-22	Glaxo Group Limited	Glaxo Group Ltd	Certificate Issued	2016-09-26	view
JXHL1400135	糠酸氟替卡松/溴化Umeclidinium/三苯乙酸维兰特罗(GW685698/ GSK573719/ GW642444)吸入粉雾剂	fluticasone furoate;umeclidinium bromide;vilanterol	Powder for inhalation	Chemical Drugs	Import Drug Application	2014-04-23	Glaxo Group Limited.	Glaxo Group Ltd	Certificate Issued	2015-05-28	view
JXHL1400053	糠酸氟替卡松/溴化Umeclidinium/三苯乙酸维兰特罗(GW685698/ GSK573719/ GW642444)吸入粉雾剂	fluticasone furoate;umeclidinium bromide;vilanterol	Powder for inhalation	Chemical Drugs	Import Drug Application	2014-02-26	Glaxo Group Limited.	Glaxo Group Ltd	Certificate Issued	2015-05-28	view